Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: An Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document.
Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: An Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document.
复制标题
DOI:
10.1093/cid/ciab761
复制
发表时间:
2022-04-28
期刊:
影响因子:
--
通讯作者:
Lee FM
中科院分区:
文献类型:
--
作者:
Greninger AL;Dien Bard J;Colgrove RC;Graf EH;Hanson KE;Hayden MK;Humphries RM;Lowe CF;Miller MB;Pillai DR;Rhoads DD;Yao JD;Lee FM
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged into a world of maturing pathogen genomics, with >2 million genomes sequenced at this writing. The rise of more transmissible variants of concern that affect vaccine and therapeutic effectiveness has led to widespread interest in SARS-CoV-2 evolution. Clinicians are also eager to take advantage of the information provided by SARS-CoV-2 genotyping beyond surveillance purposes. Here, we review the potential role of SARS-CoV-2 genotyping in clinical care. The review covers clinical use cases for SARS-CoV-2 genotyping, methods of SARS-CoV-2 genotyping, assay validation and regulatory requirements, clinical reporting for laboratories, and emerging issues in clinical SARS-CoV-2 sequencing. While clinical uses of SARS-CoV-2 genotyping are currently limited, rapid technological change along with a growing ability to interpret variants in real time foretell a growing role for SARS-CoV-2 genotyping in clinical care as continuing data emerge on vaccine and therapeutic efficacy. This article reviews the potential role of SARS-CoV-2 genotyping in clinical care. Rapid technological change along with a growing ability to interpret variants in real-time foretell a growing role for SARS-CoV-2 genotyping in clinical care.
登录
查看更多内容
影响因子:
3.7
作者:
Bhoyar RC;Jain A;Sehgal P;Divakar MK;Sharma D;Imran M;Jolly B;Ranjan G;Rophina M;Sharma S;Siwach S;Pandhare K;Sahoo S;Sahoo M;Nayak A;Mohanty JN;Das J;Bhandari S;Mathur SK;Kumar A;Sahlot R;Rojarani P;Lakshmi JV;Surekha A;Sekhar PC;Mahajan S;Masih S;Singh P;Kumar V;Jose B;Mahajan V;Gupta V;Gupta R;Arumugam P;Singh A;Nandy A;P V R;Jha RM;Kumari A;Gandotra S;Rao V;Faruq M;Kumar S;Reshma G B;Varma G N;Roy SS;Sengupta A;Chattopadhyay S;Singhal K;Pradhan S;Jha D;Naushin S;Wadhwa S;Tyagi N;Poojary M;Scaria V;Sivasubbu S
通讯作者:
Sivasubbu S
影响因子:
5.3
作者:
Duchene, Sebastian;Featherstone, Leo;Baele, Guy
通讯作者:
Baele, Guy
DOI:
10.1016/s1473-3099(20)30562-4
发表时间:
2020-11
期刊:
The Lancet. Infectious diseases
影响因子:
--
作者:
Meredith LW;Hamilton WL;Warne B;Houldcroft CJ;Hosmillo M;Jahun AS;Curran MD;Parmar S;Caller LG;Caddy SL;Khokhar FA;Yakovleva A;Hall G;Feltwell T;Forrest S;Sridhar S;Weekes MP;Baker S;Brown N;Moore E;Popay A;Roddick I;Reacher M;Gouliouris T;Peacock SJ;Dougan G;Török ME;Goodfellow I
通讯作者:
Goodfellow I
影响因子:
3.5
作者:
Alessandrini, Federica;Caucci, Sara;Menzo, Stefano
通讯作者:
Menzo, Stefano
影响因子:
56.3
作者:
Sikkema, Reina S.;Pas, Suzan D.;Koopmans, Marion P. G.
通讯作者:
Koopmans, Marion P. G.